首页 > 市场调查报告书 > 医疗设备

生技设备

市场调查报告书

商品编码

1450977

2024-2032 年按定序类型、产品类型、技术、应用、最终用户和地区分類的下一代定序市场报告

Next-Generation Sequencing Market Report by Sequencing Type, Product Type, Technology, Application, End-User, and Region 2024-2032

出版日期: 2024年03月02日 | 出版商:

IMARC | 英文 142 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

2023年全球次世代定序（NGS）市场规模达201亿美元。展望未来， IMARC Group预计到2032年市场规模将达到804亿美元，2024-2032年复合年增长率（CAGR）为16.2% 。

次世代定序 (NGS) 是一种平行定序技术，可确定脱氧核糖核酸 (DNA) 部分中的核苷酸序列。它涉及多种程序，例如合成定序（SBS）和离子半导体、单分子即时定序（SMRT）和奈米孔定序。它是一种经济高效的解决方案，可帮助医疗专业人员以高精度和高速度获得精确的结果。它还促进临床诊断、个人化和遗传医学以及农业和动物研究领域的研究。目前，它被用于药物基因组学以升级药物递送过程。

下一代定序 (NGS) 市场趋势：

全球老年人口不断增长，癌症、心血管和神经系统疾病等各种慢性疾病的盛行率不断上升，是积极影响市场的关键因素之一。这也可以归因于越来越多地使用遗传图谱来指导科学家分析导致医疗状况的基因。此外，液体活检在癌症诊断中的广泛采用，以及越来越多地利用NGS技术引入非侵入性癌症生物标记进行即时癌症监测和检测，正在创造积极的市场前景。与此一致的是，定序仪的持续技术创新，例如整合云端运算系统以增强资料安全性和管理，正在加强市场成长。除此之外，各国政府为改善医疗基础设施而持续提供的资金也为市场成长提供了动力。此外，领导企业对分子生物学、技术工程和定序化学研发 (R&D) 活动的投资不断增加，带来了良好的市场前景。

本报告回答的关键问题

2023年全球次世代定序（NGS）市场规模有多大？
2024-2032年全球次世代定序（NGS）市场的预期成长率是多少？
推动全球次世代定序（NGS）市场的关键因素是什么？
COVID-19 对全球次世代定序 (NGS) 市场有何影响？
根据定序类型，全球次世代定序（NGS）市场的细分情况如何？
根据产品类型，全球次世代定序 (NGS) 市场的细分情况如何？
基于该技术的全球次世代定序（NGS）市场的细分情况如何？
基于应用的全球次世代定序（NGS）市场的细分情况如何？
基于最终用户的全球次世代定序 (NGS) 市场的细分情况如何？
全球次世代定序（NGS）市场的关键区域有哪些？
全球次世代定序（NGS）市场的主要参与者/公司有哪些？

全基因组定序
- 市场走向
- 市场预测
标靶重测序
- 市场走向
- 市场预测
全外显子定序
- 市场走向
- 市场预测
RNA定序
- 市场走向
- 市场预测
晶片测序
- 市场走向
- 市场预测
从头测序
- 市场走向
- 市场预测
甲基定序
- 市场走向
- 市场预测
其他的
- 市场走向
- 市场预测

第 7 章：市场区隔：依产品类型

仪器
- 市场走向
- 市场预测
试剂及耗材
- 市场走向
- 市场预测
软体和服务
- 市场走向
- 市场预测

第 8 章：市场区隔：依技术

定序：合成法
- 市场走向
- 市场预测
离子半导体定序
- 市场走向
- 市场预测
单分子即时定序
- 市场走向
- 市场预测
奈米孔定序
- 市场走向
- 市场预测
其他的
- 市场走向
- 市场预测

第 9 章：市场区隔：按应用

生物标记与癌症
- 市场走向
- 市场预测
药物发现与个人化医疗
- 市场走向
- 市场预测
基因筛检
- 市场走向
- 市场预测
诊断
- 市场走向
- 市场预测
农业和动物研究
- 市场走向
- 市场预测
其他的
- 市场走向
- 市场预测

第 10 章：市场区隔：依最终用户

学术机构与研究中心
- 市场走向
- 市场预测
医院和诊所
- 市场走向
- 市场预测
製药与生物技术公司
- 市场走向
- 市场预测
其他的
- 市场走向
- 市场预测

第 11 章：市场区隔：按地区

北美洲
- 美国
  - 市场走向
  - 市场预测
- 加拿大
  - 市场走向
  - 市场预测
亚太地区
- 中国
  - 市场走向
  - 市场预测
- 日本
  - 市场走向
  - 市场预测
- 印度
  - 市场走向
  - 市场预测
- 韩国
  - 市场走向
  - 市场预测
- 澳洲
  - 市场走向
  - 市场预测
- 印尼
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
欧洲
- 德国
  - 市场走向
  - 市场预测
- 法国
  - 市场走向
  - 市场预测
- 英国
  - 市场走向
  - 市场预测
- 义大利
  - 市场走向
  - 市场预测
- 西班牙
  - 市场走向
  - 市场预测
- 俄罗斯
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
拉丁美洲
- 巴西
  - 市场走向
  - 市场预测
- 墨西哥
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
中东和非洲
- 市场走向
- 市场细分：按国家/地区
- 市场预测

第 12 章：SWOT 分析

概述
优势
弱点
机会
威胁

第 13 章：价值链分析

第 14 章：波特五力分析

概述
买家的议价能力
供应商的议价能力
竞争程度
新进入者的威胁
替代品的威胁

第 15 章：价格指标

第16章：竞争格局

市场结构
关键参与者
关键参与者简介
- Agilent Technologies Inc.
- Becton Dickinson and Company
- 10x Genomics
- BGI Group
- Eurofins Scientific
- F. Hoffmann-La Roche AG
- Illumina Inc.
- Genewiz
- Macrogen Inc.
- Oxford Nanopore Technologies
- Pacific Biosciences
- Perkinelmer Inc.
- Thermo Fisher Scientific Inc.
- Qiagen NV
- Genapsys Inc.

简介目录图表

Product Code: SR112024A2039

The global next-generation sequencing (NGS) market size reached US$ 20.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 80.4 Billion by 2032, exhibiting a growth rate (CAGR) of 16.2% during 2024-2032.

Next-generation sequencing (NGS) is a parallel sequencing technology that determines the sequence of nucleotides in a section of the deoxyribonucleic acid (DNA). It involves various procedures, such as sequencing by synthesis (SBS) and ion semiconductor, single-molecule real-time (SMRT), and nanopore sequencing. It is a cost-effective solution that assists medical professionals in achieving precise results with high accuracy and speed. It also facilitates research in the fields of clinical diagnostics, personalized and genetic medicines, and agriculture and animal studies. At present, it is utilized in pharmacogenomics to escalate the drug delivery process.

Next-Generation Sequencing (NGS) Market Trends:

The growing global geriatric population and the rising prevalence of various chronic medical disorders, such as cancer, cardiovascular, and neurological disorders, represent one of the key factors positively influencing the market. It can also be attributed to the growing use of genetic maps for guiding scientists to analyze the genes that are responsible for medical conditions. In addition, the widespread adoption of liquid biopsies in cancer diagnostics and the increasing utilization of NGS technologies to introduce non-invasive cancer biomarkers for real-time cancer monitoring and detection are creating a positive market outlook. In line with this, continuous technological innovations in sequencers, such as the integration of cloud-computing systems for enhanced data security and management, are strengthening the market growth. Apart from this, continuous financing by governments of various countries to improve healthcare infrastructure is providing a thrust to the market growth. Furthermore, increasing investments by leading players in research and development (R&D) activities for molecular biology, technical engineering, and sequencing chemistry is offering a favorable market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global next-generation sequencing (NGS) market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on sequencing type, product type, technology, application and end-user.

Breakup by Sequencing Type:

Whole Genome Sequencing

Targeted Resequencing

Whole Exome Sequencing

RNA Sequencing

CHIP Sequencing

De Novo Sequencing

Methyl Sequencing

Others

Targeted resequencing represents the largest market segment due to the presence of numerous companies in the NGS market offering targeted resequencing services.

Breakup by Product Type:

Instruments

Reagents and Consumables

Software and Services

Reagents and consumables represent the most commonly used product type that assists in sample preparation, DNA isolation, sample cleanup, target enrichment, and quality assurance.

Breakup by Technology:

Sequencing by Synthesis

Ion Semiconductor Sequencing

Single-Molecule Real-Time Sequencing

Nanopore Sequencing

Others

Sequencing by synthesis finds extensive applications on account of its high accuracy in performing DNA sequencing and its growing incorporation in NGS instrumentation. In addition, it offers the highest yield of error-free throughput results.

Breakup by Application:

Biomarker and Cancer

Drug Discovery and Personalized Medicine

Genetic Screening

Diagnostics

Agriculture and Animal Research

Others

Biomarker and cancer currently dominate the market due to the rising prevalence of cancer and increasing awareness among individuals about the benefits of early diagnosis and treatment.

Breakup by End-User:

Academic Institutes & Research Centers

Hospitals & Clinics

Pharmaceutical & Biotechnology Companies

Others

Academic institutes and research centers account for the majority of the market share due to the increasing application of NGS solutions in research projects.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market due to the availability of a technologically advanced healthcare research framework in the region, coupled with the presence of multiple clinical laboratories that employ NGS to provide genetic testing services.

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies, Becton Dickinson and Company, 10x Genomics, BGI Group, Eurofins Scientific, F. Hoffmann-La Roche AG, Illumina Inc., Genewiz, Macrogen, Oxford Nanopore Technologies, Pacific Biosciences, PerkinElmer, Thermo Fisher Scientific, Qiagen N.V., GenapSys Inc., etc.

Key Questions Answered in This Report

1. What was the size of the global next-generation sequencing (NGS) market in 2023?
2. What is the expected growth rate of the global next-generation sequencing (NGS) market during 2024-2032?
3. What are the key factors driving the global next-generation sequencing (NGS) market?
4. What has been the impact of COVID-19 on the global next-generation sequencing (NGS) market?
5. What is the breakup of the global next-generation sequencing (NGS) market based on the sequencing type?
6. What is the breakup of the global next-generation sequencing (NGS) market based on the product type?
7. What is the breakup of the global next-generation sequencing (NGS) market based on the technology?
8. What is the breakup of the global next-generation sequencing (NGS) market based on the application?
9. What is the breakup of the global next-generation sequencing (NGS) market based on the end- user?
10. What are the key regions in the global next-generation sequencing (NGS) market?
11. Who are the key players/companies in the global next-generation sequencing (NGS) market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Next-Generation Sequencing Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Sequencing Type

6.1 Whole Genome Sequencing
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Targeted Resequencing
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Whole Exome Sequencing
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 RNA Sequencing
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 CHIP Sequencing
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
6.6 De Novo Sequencing
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
6.7 Methyl Sequencing
- 6.7.1 Market Trends
- 6.7.2 Market Forecast
6.8 Others
- 6.8.1 Market Trends
- 6.8.2 Market Forecast

7 Market Breakup by Product Type

7.1 Instruments
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Reagents and Consumables
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Software and Services
- 7.3.1 Market Trends
- 7.3.2 Market Forecast

8 Market Breakup by Technology

8.1 Sequencing by Synthesis
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Ion Semiconductor Sequencing
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Single-Molecule Real-Time Sequencing
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Nanopore Sequencing
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast

9 Market Breakup by Application

9.1 Biomarker and Cancer
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Drug Discovery and Personalized Medicine
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Genetic Screening
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 Diagnostics
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
9.5 Agriculture and Animal Research
- 9.5.1 Market Trends
- 9.5.2 Market Forecast
9.6 Others
- 9.6.1 Market Trends
- 9.6.2 Market Forecast

10 Market Breakup by End-User

10.1 Academic Institutes & Research Centers
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
10.2 Hospitals & Clinics
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
10.3 Pharmaceutical & Biotechnology Companies
- 10.3.1 Market Trends
- 10.3.2 Market Forecast
10.4 Others
- 10.4.1 Market Trends
- 10.4.2 Market Forecast

11 Market Breakup by Region

11.1 North America
- 11.1.1 United States
  - 11.1.1.1 Market Trends
  - 11.1.1.2 Market Forecast
- 11.1.2 Canada
  - 11.1.2.1 Market Trends
  - 11.1.2.2 Market Forecast
11.2 Asia Pacific
- 11.2.1 China
  - 11.2.1.1 Market Trends
  - 11.2.1.2 Market Forecast
- 11.2.2 Japan
  - 11.2.2.1 Market Trends
  - 11.2.2.2 Market Forecast
- 11.2.3 India
  - 11.2.3.1 Market Trends
  - 11.2.3.2 Market Forecast
- 11.2.4 South Korea
  - 11.2.4.1 Market Trends
  - 11.2.4.2 Market Forecast
- 11.2.5 Australia
  - 11.2.5.1 Market Trends
  - 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
  - 11.2.6.1 Market Trends
  - 11.2.6.2 Market Forecast
- 11.2.7 Others
  - 11.2.7.1 Market Trends
  - 11.2.7.2 Market Forecast
11.3 Europe
- 11.3.1 Germany
  - 11.3.1.1 Market Trends
  - 11.3.1.2 Market Forecast
- 11.3.2 France
  - 11.3.2.1 Market Trends
  - 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
  - 11.3.3.1 Market Trends
  - 11.3.3.2 Market Forecast
- 11.3.4 Italy
  - 11.3.4.1 Market Trends
  - 11.3.4.2 Market Forecast
- 11.3.5 Spain
  - 11.3.5.1 Market Trends
  - 11.3.5.2 Market Forecast
- 11.3.6 Russia
  - 11.3.6.1 Market Trends
  - 11.3.6.2 Market Forecast
- 11.3.7 Others
  - 11.3.7.1 Market Trends
  - 11.3.7.2 Market Forecast
11.4 Latin America
- 11.4.1 Brazil
  - 11.4.1.1 Market Trends
  - 11.4.1.2 Market Forecast
- 11.4.2 Mexico
  - 11.4.2.1 Market Trends
  - 11.4.2.2 Market Forecast
- 11.4.3 Others
  - 11.4.3.1 Market Trends
  - 11.4.3.2 Market Forecast
11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast

12 SWOT Analysis

12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes

15 Price Indicators

16 Competitive Landscape

16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
- 16.3.1 Agilent Technologies Inc.
  - 16.3.1.1 Company Overview
  - 16.3.1.2 Product Portfolio
  - 16.3.1.3 Financials
  - 16.3.1.4 SWOT Analysis
- 16.3.2 Becton Dickinson and Company
  - 16.3.2.1 Company Overview
  - 16.3.2.2 Product Portfolio
  - 16.3.2.3 Financials
  - 16.3.2.4 SWOT Analysis
- 16.3.3 10x Genomics
  - 16.3.3.1 Company Overview
  - 16.3.3.2 Product Portfolio
- 16.3.4 BGI Group
  - 16.3.4.1 Company Overview
  - 16.3.4.2 Product Portfolio
- 16.3.5 Eurofins Scientific
  - 16.3.5.1 Company Overview
  - 16.3.5.2 Product Portfolio
- 16.3.6 F. Hoffmann-La Roche AG
  - 16.3.6.1 Company Overview
  - 16.3.6.2 Product Portfolio
  - 16.3.6.3 Financials
- 16.3.7 Illumina Inc.
  - 16.3.7.1 Company Overview
  - 16.3.7.2 Product Portfolio
  - 16.3.7.3 Financials
  - 16.3.7.4 SWOT Analysis
- 16.3.8 Genewiz
  - 16.3.8.1 Company Overview
  - 16.3.8.2 Product Portfolio
- 16.3.9 Macrogen Inc.
  - 16.3.9.1 Company Overview
  - 16.3.9.2 Product Portfolio
  - 16.3.9.3 Financials
- 16.3.10 Oxford Nanopore Technologies
  - 16.3.10.1 Company Overview
  - 16.3.10.2 Product Portfolio
  - 16.3.10.3 Financials
  - 16.3.10.4 SWOT Analysis
- 16.3.11 Pacific Biosciences
  - 16.3.11.1 Company Overview
  - 16.3.11.2 Product Portfolio
  - 16.3.11.3 Financials
- 16.3.12 Perkinelmer Inc.
  - 16.3.12.1 Company Overview
  - 16.3.12.2 Product Portfolio
  - 16.3.12.3 Financials
  - 16.3.12.4 SWOT Analysis
- 16.3.13 Thermo Fisher Scientific Inc.
  - 16.3.13.1 Company Overview
  - 16.3.13.2 Product Portfolio
  - 16.3.13.3 Financials
  - 16.3.13.4 SWOT Analysis
- 16.3.14 Qiagen N.V.
  - 16.3.14.1 Company Overview
  - 16.3.14.2 Product Portfolio
  - 16.3.14.3 Financials
  - 16.3.14.4 SWOT Analysis
- 16.3.15 Genapsys Inc.
  - 16.3.15.1 Company Overview
  - 16.3.15.2 Product Portfolio

简介目录图表

List of Figures

Figure 1: Global: Next-Generation Sequencing Market: Major Drivers and Challenges
Figure 2: Global: Next-Generation Sequencing Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Next-Generation Sequencing Market: Breakup by Sequencing Type (in %), 2023
Figure 4: Global: Next-Generation Sequencing Market: Breakup by Product Type (in %), 2023
Figure 5: Global: Next-Generation Sequencing Market: Breakup by Technology (in %), 2023
Figure 6: Global: Next-Generation Sequencing Market: Breakup by Application (in %), 2023
Figure 7: Global: Next-Generation Sequencing Market: Breakup by End-User (in %), 2023
Figure 8: Global: Next-Generation Sequencing Market: Breakup by Region (in %), 2023
Figure 9: Global: Next-Generation Sequencing Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 10: Global: Next-Generation Sequencing (Whole Genome Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Next-Generation Sequencing (Whole Genome Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Next-Generation Sequencing (Targeted Resequencing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Next-Generation Sequencing (Targeted Resequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Next-Generation Sequencing (Whole Exome Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Next-Generation Sequencing (Whole Exome Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Next-Generation Sequencing (RNA Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Next-Generation Sequencing (RNA Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Next-Generation Sequencing (CHIP Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Next-Generation Sequencing (CHIP Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Next-Generation Sequencing (De Novo Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Next-Generation Sequencing (De Novo Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Next-Generation Sequencing (Methyl Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Next-Generation Sequencing (Methyl Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Next-Generation Sequencing (Other Sequencing Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Next-Generation Sequencing (Other Sequencing Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Next-Generation Sequencing (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Next-Generation Sequencing (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Next-Generation Sequencing (Reagents and Consumables) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Next-Generation Sequencing (Reagents and Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Next-Generation Sequencing (Software and Services) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Next-Generation Sequencing (Software and Services) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Next-Generation Sequencing (Sequencing by Synthesis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Next-Generation Sequencing (Sequencing by Synthesis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Global: Next-Generation Sequencing (Ion Semiconductor Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Global: Next-Generation Sequencing (Ion Semiconductor Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Global: Next-Generation Sequencing (Single-Molecule Real-Time Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Global: Next-Generation Sequencing (Single-Molecule Real-Time Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Global: Next-Generation Sequencing (Nanopore Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Global: Next-Generation Sequencing (Nanopore Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Global: Next-Generation Sequencing (Others) Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Global: Next-Generation Sequencing (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Global: Next-Generation Sequencing (Biomarker and Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Global: Next-Generation Sequencing (Biomarker and Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Global: Next-Generation Sequencing (Drug Discovery and Personalized Medicine) Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Global: Next-Generation Sequencing (Drug Discovery and Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Global: Next-Generation Sequencing (Genetic Screening) Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Global: Next-Generation Sequencing (Genetic Screening) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Global: Next-Generation Sequencing (Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Global: Next-Generation Sequencing (Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Global: Next-Generation Sequencing (Agriculture and Animal Research) Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Global: Next-Generation Sequencing (Agriculture and Animal Research) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Global: Next-Generation Sequencing (Others) Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Global: Next-Generation Sequencing (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Global: Next-Generation Sequencing (Academic Institutes & Research Centers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Global: Next-Generation Sequencing (Academic Institutes & Research Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Global: Next-Generation Sequencing (Hospitals & Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Global: Next-Generation Sequencing (Hospitals & Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Global: Next-Generation Sequencing (Pharmaceutical & Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Global: Next-Generation Sequencing (Pharmaceutical & Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Global: Next-Generation Sequencing (Others) Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Global: Next-Generation Sequencing (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: North America: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: North America: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: United States: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: United States: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Canada: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Canada: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Asia Pacific: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Asia Pacific: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: China: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: China: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Japan: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Japan: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: India: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: India: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: South Korea: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: South Korea: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Australia: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Australia: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Indonesia: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: Indonesia: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Others: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
Figure 83: Others: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 84: Europe: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
Figure 85: Europe: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 86: Germany: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
Figure 87: Germany: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 88: France: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
Figure 89: France: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 90: United Kingdom: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
Figure 91: United Kingdom: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 92: Italy: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
Figure 93: Italy: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 94: Spain: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
Figure 95: Spain: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 96: Russia: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
Figure 97: Russia: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 98: Others: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
Figure 99: Others: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 100: Latin America: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
Figure 101: Latin America: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 102: Brazil: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
Figure 103: Brazil: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 104: Mexico: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
Figure 105: Mexico: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 106: Others: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
Figure 107: Others: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 108: Middle East and Africa: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
Figure 109: Middle East and Africa: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 110: Global: Next-Generation Sequencing Industry: SWOT Analysis
Figure 111: Global: Next-Generation Sequencing Industry: Value Chain Analysis
Figure 112: Global: Next-Generation Sequencing Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Next-Generation Sequencing Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Next-Generation Sequencing Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
Table 3: Global: Next-Generation Sequencing Market Forecast: Breakup by Sequencing Type (in Million US$), 2024-2032
Table 4: Global: Next-Generation Sequencing Market Forecast: Breakup by Technology (in Million US$), 2024-2032
Table 5: Global: Next-Generation Sequencing Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 6: Global: Next-Generation Sequencing Market Forecast: Breakup by End-User (in Million US$), 2024-2032
Table 7: Global: Next-Generation Sequencing Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 8: Global: Next-Generation Sequencing Market Structure
Table 9: Global: Next-Generation Sequencing Market: Key Players

02-2729-4219

+886-2-2729-4219